REGENERON PHARMACEUTICALS, INC. (REGN) Stock buybacks 2016–2025
REGENERON PHARMACEUTICALS, INC. (REGN) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$3.4BFY2025 · since FY2016: $0 → $3.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.4B | +32.1% |
| FY2024 | $2.6B | +16.5% |
| FY2023 | $2.2B | +7.3% |
| FY2022 | $2.1B | +26.6% |
| FY2021 | $1.6B | -71.9% |
| FY2020 | $5.8B | +2019.2% |
| FY2019 | $275.9M | +6170.5% |
| FY2018 | $4.4M | — |
| FY2017 | $0 | — |
| FY2016 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More REGN financial trends
REGN RevenueREGN Net incomeREGN Net marginREGN Gross profitREGN Gross marginREGN Operating incomeREGN Operating marginREGN Operating cash flowREGN Free cash flowREGN Capital expendituresREGN Return on equityREGN Dividends paidREGN Total assetsREGN Total liabilitiesREGN Shareholders’ equityREGN overview →